Market Closed

SPRO
Spero Therapeutics
$ 0.9999
-0.01%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

Spero Therapeutics News

Latest Spero Therapeutics Stock News & SPRO Headlines

Spero Therapeutics to Present at Investor Conferences in November
13 days ago | globenewswire.com
This Spero Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
19 days ago | benzinga.com
Spero Therapeutics Targets 2027 Phase II Launch for SP001 in IgG4-Related Disease
a month ago | marketbeat.com
Spero Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference
a month ago | globenewswire.com
Spero Therapeutics, Inc. (SPRO) Q2 2026 Earnings Call Transcript
3 months ago | seekingalpha.com
Spero Therapeutics Q2 Earnings Call Highlights
3 months ago | marketbeat.com
Spero Therapeutics Announces Second Quarter 2026 Operating Results and Provides Business Update
3 months ago | globenewswire.com
Spero Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026
3 months ago | globenewswire.com
Spero Therapeutics Appoints Debra Jeske Zack, M.D., Ph.D., as Chief Medical Officer
4 months ago | globenewswire.com
Spero Therapeutics: 'Buy' On Utebzi Royalty Deal For Funding And SP001 In-Licensing
4 months ago | seekingalpha.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

SPRO
Spero Therapeutics
$ 0.9999
-0.01%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago